Barclays’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $356K | Buy |
361,709
+125,576
| +53% | +$124K | ﹤0.01% | 3216 |
|
|
2025
Q1 | $340K | Sell |
236,133
-123,102
| -34% | -$177K | ﹤0.01% | 3059 |
|
|
2024
Q4 | $791K | Buy |
359,235
+49,564
| +16% | +$109K | ﹤0.01% | 2773 |
|
|
2024
Q3 | $510K | Buy |
309,671
+154,509
| +100% | +$254K | ﹤0.01% | 2983 |
|
|
2024
Q2 | $344K | Buy |
155,162
+50,678
| +49% | +$112K | ﹤0.01% | 2747 |
|
|
2024
Q1 | $280K | Sell |
104,484
-16,600
| -14% | -$44.5K | ﹤0.01% | 3156 |
|
|
2023
Q4 | $362K | Buy |
121,084
+32,100
| +36% | +$96K | ﹤0.01% | 3190 |
|
|
2023
Q3 | $87K | Sell |
88,984
-14,664
| -14% | -$14.3K | ﹤0.01% | 3371 |
|
|
2023
Q2 | $144K | Sell |
103,648
-56,779
| -35% | -$78.9K | ﹤0.01% | 3243 |
|
|
2023
Q1 | $255K | Sell |
160,427
-2,594
| -2% | -$4.12K | ﹤0.01% | 3022 |
|
|
2022
Q4 | $1.02M | Buy |
163,021
+121,325
| +291% | +$757K | ﹤0.01% | 2117 |
|
|
2022
Q3 | $280K | Buy |
41,696
+13,617
| +48% | +$91.4K | ﹤0.01% | 2904 |
|
|
2022
Q2 | $178K | Sell |
28,079
-6,983
| -20% | -$44.3K | ﹤0.01% | 3200 |
|
|
2022
Q1 | $163K | Sell |
35,062
-60,636
| -63% | -$282K | ﹤0.01% | 3435 |
|
|
2021
Q4 | $480K | Buy |
95,698
+47,092
| +97% | +$236K | ﹤0.01% | 2548 |
|
|
2021
Q3 | $585K | Buy |
48,606
+14,300
| +42% | +$172K | ﹤0.01% | 2532 |
|
|
2021
Q2 | $726K | Sell |
34,306
-3,714
| -10% | -$78.6K | ﹤0.01% | 2286 |
|
|
2021
Q1 | $1.07M | Sell |
38,020
-17,605
| -32% | -$494K | ﹤0.01% | 2264 |
|
|
2020
Q4 | $1.45M | Buy |
55,625
+43,764
| +369% | +$1.14M | ﹤0.01% | 1774 |
|
|
2020
Q3 | $441K | Sell |
11,861
-173,332
| -94% | -$6.44M | ﹤0.01% | 2369 |
|
|
2020
Q2 | $9.5M | Buy |
185,193
+5,985
| +3% | +$307K | 0.01% | 682 |
|
|
2020
Q1 | $5.65M | Buy |
179,208
+71,195
| +66% | +$2.24M | ﹤0.01% | 822 |
|
|
2019
Q4 | $6.44M | Buy |
108,013
+83,406
| +339% | +$4.97M | ﹤0.01% | 1073 |
|
|
2019
Q3 | $903K | Sell |
24,607
-7,495
| -23% | -$275K | ﹤0.01% | 2319 |
|
|
2019
Q2 | $1.49M | Buy |
32,102
+24,108
| +302% | +$1.12M | ﹤0.01% | 2036 |
|
|
2019
Q1 | $321K | Sell |
7,994
-3,314
| -29% | -$133K | ﹤0.01% | 2821 |
|
|
2018
Q4 | $520K | Buy |
11,308
+2,730
| +32% | +$126K | ﹤0.01% | 2240 |
|
|
2018
Q3 | $381K | Buy |
8,578
+2,491
| +41% | +$111K | ﹤0.01% | 2766 |
|
|
2018
Q2 | $239K | Sell |
6,087
-19,693
| -76% | -$773K | ﹤0.01% | 2659 |
|
|
2018
Q1 | $1.86M | Sell |
25,780
-39,917
| -61% | -$2.89M | ﹤0.01% | 1409 |
|
|
2017
Q4 | $4.33M | Buy |
65,697
+64,158
| +4,169% | +$4.22M | ﹤0.01% | 928 |
|
|
2017
Q3 | $77K | Sell |
1,539
-76,167
| -98% | -$3.81M | ﹤0.01% | 2800 |
|
|
2017
Q2 | $3.6M | Buy |
77,706
+58,431
| +303% | +$2.7M | ﹤0.01% | 931 |
|
|
2017
Q1 | $681K | Buy |
19,275
+3,123
| +19% | +$110K | ﹤0.01% | 1791 |
|
|
2016
Q4 | $201K | Buy |
16,152
+15,878
| +5,795% | +$198K | ﹤0.01% | 2299 |
|
|
2016
Q3 | $4K | Sell |
274
-114
| -29% | -$1.66K | ﹤0.01% | 3459 |
|
|
2016
Q2 | $4K | Buy |
388
+200
| +106% | +$2.06K | ﹤0.01% | 3152 |
|
|
2016
Q1 | $3K | Sell |
188
-1,487
| -89% | -$23.7K | ﹤0.01% | 3146 |
|
|
2015
Q4 | $37K | Sell |
1,675
-37,708
| -96% | -$833K | ﹤0.01% | 2565 |
|
|
2015
Q3 | $904K | Buy |
39,383
+34,480
| +703% | +$791K | ﹤0.01% | 1464 |
|
|
2015
Q2 | $397K | Buy |
4,903
+3,754
| +327% | +$304K | ﹤0.01% | 1849 |
|
|
2015
Q1 | $105K | Buy |
1,149
+247
| +27% | +$22.6K | ﹤0.01% | 2490 |
|
|
2014
Q4 | $36K | Sell |
902
-749
| -45% | -$29.9K | ﹤0.01% | 3180 |
|
|
2014
Q3 | $39K | Sell |
1,651
-1,865
| -53% | -$44.1K | ﹤0.01% | 3118 |
|
|
2014
Q2 | $53K | Buy |
3,516
+779
| +28% | +$11.7K | ﹤0.01% | 3007 |
|
|
2014
Q1 | $41K | Buy |
2,737
+2,635
| +2,583% | +$39.5K | ﹤0.01% | 3259 |
|
|
2013
Q4 | $1K | Sell |
102
-248
| -71% | -$2.43K | ﹤0.01% | 4250 |
|
|
2013
Q3 | $7K | Buy |
+350
| New | +$7K | ﹤0.01% | 3725 |
|